Darrenneoyo
2021-11-28
Yay pfizer!
Pfizer’s Pill, Shot Help Push Stock to Record as Variant Emerges
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
2
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":600186666,"tweetId":"600186666","gmtCreate":1638091659131,"gmtModify":1638091659346,"author":{"id":3572866150582582,"idStr":"3572866150582582","authorId":3572866150582582,"authorIdStr":"3572866150582582","name":"Darrenneoyo","avatar":"https://static.tigerbbs.com/19498d498955308da03ff537c16af7b0","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":48,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Yay pfizer!</p></body></html>","htmlText":"<html><head></head><body><p>Yay pfizer!</p></body></html>","text":"Yay pfizer!","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/600186666","repostId":2186116341,"repostType":2,"repost":{"id":"2186116341","kind":"news","pubTimestamp":1637946362,"share":"https://ttm.financial/m/news/2186116341?lang=&edition=full","pubTime":"2021-11-27 01:06","market":"us","language":"en","title":"Pfizer’s Pill, Shot Help Push Stock to Record as Variant Emerges","url":"https://stock-news.laohu8.com/highlight/detail?id=2186116341","media":"Bloomberg","summary":"(Bloomberg) -- Pfizer Inc. jumped to a record Friday on the promise of its Covid-19 vaccine and anti","content":"<html><body><p>(Bloomberg) -- Pfizer Inc. jumped to a record Friday on the promise of its Covid-19 vaccine and antiviral pill even as fears of a new variant tamped down much of the rest of the U.S. stock market.</p>\n<p>Most Read from Bloomberg</p>\n<ul>\n<li>Billionaire Family Feud Puts a Century-Old Business Empire in Jeopardy</li>\n<li>Asia’s Richest Man Looks to Walton Family Playbook on Succession</li>\n<li>The 24-Year-Old Aiming to Dethrone Victoria’s Secret</li>\n<li>An Arab City’s Booming Art Scene Is Also a Grab at Soft Power</li>\n<li>The Winners and Losers From a Year of Ranking Covid Resilience</li>\n</ul>\n<p>The drug maker added more than $17 billion to it market value as the shares climbed 6.1% at 12:02 p.m. in New York trading. Pfizer’s vaccine with <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> is now the best-selling drug product on a yearly basis and received backing from a European regulatory panel on Thursday to expand its use into children as young as five. BioNtech shares surged 21%.</p>\n<p>New York-based Pfizer is waiting to hear back from U.S. regulators on a new Covid pill, Paxlovid. The company filed for an emergency use authorization for the medicine on Nov. 16. Friday’s results from Merck & Co.’s competing pill appeared less effective than prior estimates. </p>\n<p>The new variant, B.1.1.529 also being called “Nu,” was first identified in South Africa and infected two people quarantined in a hotel in Hong Kong. “In the event that [a] vaccine-escape variant emerges, Pfizer and BioNTech expect to be able to develop and produce a tailor-made vaccine against that variant in approximately 100 days, subject to regulatory approval,” a company spokeswoman said in an email. </p>\n<p>The next two weeks will be critical, said $Citigroup Inc(C-N)$. analyst Andrew Baum. “Concern over Nu needs to be balanced against the failure of other concerning variants such as Beta (also first identified in Africa) to out-compete delta,” he said. The new antivirals should still work against the variant though resistance may eventually appear, he wrote in a research note. </p>\n<p>Pfizer’s stock is up more than 45% this year. Other vaccine stocks also rallied on Friday with Moderna Inc. jumping as much as 28% for the biggest climb in over 17 months.</p>\n<p>Most Read from Bloomberg Businessweek</p>\n<ul>\n<li>Medical Debt Is Crushing Black Americans, and Hospitals Aren’t Helping</li>\n<li>Wildfires Are Getting Worse, and One Chemical Company Is Reaping the Benefits</li>\n<li>How Child Care Became the Most Broken Business in America</li>\n</ul>\n<p>©2021 Bloomberg L.P.</p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer’s Pill, Shot Help Push Stock to Record as Variant Emerges</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer’s Pill, Shot Help Push Stock to Record as Variant Emerges\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-27 01:06 GMT+8 <a href=https://finance.yahoo.com/news/pfizer-pill-shot-help-push-170602114.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- Pfizer Inc. jumped to a record Friday on the promise of its Covid-19 vaccine and antiviral pill even as fears of a new variant tamped down much of the rest of the U.S. stock market.\n...</p>\n\n<a href=\"https://finance.yahoo.com/news/pfizer-pill-shot-help-push-170602114.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://s.yimg.com/uu/api/res/1.2/P9GGnAtVEfkKkYPS.m54gA--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/QBeRTgTVJ5ZTB_xtm.aKSg--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/bloomberg_markets_842/eecc68aec5ebe3bfc759e8832ab15b32","relate_stocks":{"PFE":"辉瑞","BK4551":"寇图资本持仓","BK4568":"美国抗疫概念","BK4550":"红杉资本持仓","BK4007":"制药","BK4534":"瑞士信贷持仓","BK4139":"生物科技","BK4548":"巴美列捷福持仓","BK4535":"淡马锡持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BNTX":"BioNTech SE"},"source_url":"https://finance.yahoo.com/news/pfizer-pill-shot-help-push-170602114.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2186116341","content_text":"(Bloomberg) -- Pfizer Inc. jumped to a record Friday on the promise of its Covid-19 vaccine and antiviral pill even as fears of a new variant tamped down much of the rest of the U.S. stock market.\nMost Read from Bloomberg\n\nBillionaire Family Feud Puts a Century-Old Business Empire in Jeopardy\nAsia’s Richest Man Looks to Walton Family Playbook on Succession\nThe 24-Year-Old Aiming to Dethrone Victoria’s Secret\nAn Arab City’s Booming Art Scene Is Also a Grab at Soft Power\nThe Winners and Losers From a Year of Ranking Covid Resilience\n\nThe drug maker added more than $17 billion to it market value as the shares climbed 6.1% at 12:02 p.m. in New York trading. Pfizer’s vaccine with BioNTech SE is now the best-selling drug product on a yearly basis and received backing from a European regulatory panel on Thursday to expand its use into children as young as five. BioNtech shares surged 21%.\nNew York-based Pfizer is waiting to hear back from U.S. regulators on a new Covid pill, Paxlovid. The company filed for an emergency use authorization for the medicine on Nov. 16. Friday’s results from Merck & Co.’s competing pill appeared less effective than prior estimates. \nThe new variant, B.1.1.529 also being called “Nu,” was first identified in South Africa and infected two people quarantined in a hotel in Hong Kong. “In the event that [a] vaccine-escape variant emerges, Pfizer and BioNTech expect to be able to develop and produce a tailor-made vaccine against that variant in approximately 100 days, subject to regulatory approval,” a company spokeswoman said in an email. \nThe next two weeks will be critical, said $Citigroup Inc(C-N)$. analyst Andrew Baum. “Concern over Nu needs to be balanced against the failure of other concerning variants such as Beta (also first identified in Africa) to out-compete delta,” he said. The new antivirals should still work against the variant though resistance may eventually appear, he wrote in a research note. \nPfizer’s stock is up more than 45% this year. Other vaccine stocks also rallied on Friday with Moderna Inc. jumping as much as 28% for the biggest climb in over 17 months.\nMost Read from Bloomberg Businessweek\n\nMedical Debt Is Crushing Black Americans, and Hospitals Aren’t Helping\nWildfires Are Getting Worse, and One Chemical Company Is Reaping the Benefits\nHow Child Care Became the Most Broken Business in America\n\n©2021 Bloomberg L.P.","news_type":1,"symbols_score_info":{"BNTX":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":1784,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":10,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/600186666"}
精彩评论